Insufficient scRNA-seq data for expression of ESS2 at single-cell level.
Insufficient scRNA-seq data for expression of ESS2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1241.82 | 1445 / 1445 | 100% | 9.35 | 183 / 183 |
thymus | 100% | 1145.36 | 653 / 653 | 100% | 13.88 | 605 / 605 |
uterus | 100% | 1414.53 | 170 / 170 | 100% | 15.70 | 459 / 459 |
brain | 100% | 1138.94 | 2640 / 2642 | 100% | 20.02 | 705 / 705 |
skin | 100% | 1498.19 | 1809 / 1809 | 100% | 18.55 | 471 / 472 |
prostate | 100% | 1249.82 | 245 / 245 | 100% | 10.92 | 500 / 502 |
ovary | 100% | 1202.08 | 180 / 180 | 100% | 9.59 | 428 / 430 |
kidney | 100% | 841.17 | 89 / 89 | 99% | 10.34 | 895 / 901 |
bladder | 100% | 1303.62 | 21 / 21 | 99% | 12.60 | 498 / 504 |
intestine | 100% | 1198.35 | 966 / 966 | 99% | 9.23 | 520 / 527 |
stomach | 100% | 927.64 | 359 / 359 | 99% | 9.05 | 282 / 286 |
pancreas | 99% | 548.12 | 325 / 328 | 99% | 10.37 | 177 / 178 |
lung | 100% | 925.06 | 577 / 578 | 99% | 11.79 | 1138 / 1155 |
breast | 100% | 1154.60 | 459 / 459 | 98% | 11.01 | 1099 / 1118 |
adrenal gland | 100% | 923.36 | 258 / 258 | 98% | 10.13 | 226 / 230 |
liver | 100% | 511.77 | 226 / 226 | 98% | 7.72 | 398 / 406 |
adipose | 100% | 1082.34 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 18.60 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 16.60 | 29 / 29 |
spleen | 100% | 1286.29 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 14.41 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 12.11 | 1 / 1 |
blood vessel | 100% | 1252.35 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 734.85 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 634.54 | 853 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 1062.40 | 915 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0007399 | Biological process | nervous system development |
GO_0071013 | Cellular component | catalytic step 2 spliceosome |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | ESS2 |
Protein name | Splicing factor ESS-2 homolog (DiGeorge syndrome critical region 13) (DiGeorge syndrome critical region 14) (DiGeorge syndrome protein H) (DGS-H) (Protein ES2) Ess-2 splicing factor homolog |
Synonyms | ES2 DGSH DGCR14 DGCR13 DGSI |
Description | FUNCTION: May be involved in pre-mRNA splicing. . |
Accessions | ENST00000434568.5 ENST00000252137.11 F8WEF8 Q96DF8 |